Opthea Ltd (OPT)
3.39
-0.35
(-9.36%)
USD |
NASDAQ |
Nov 14, 16:00
3.39
0.00 (0.00%)
After-Hours: 16:29
Opthea Debt to Equity Ratio: -1.867 for June 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2024 | -1.867 |
| December 31, 2023 | 0.00 |
| June 30, 2023 | -14.63 |
| December 31, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| December 31, 2019 | 0.0052 |
| June 30, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2011 | 0.00 |
| June 30, 2011 | 0.00 |
| December 31, 2010 | 0.00 |
| June 30, 2010 | 0.00 |
| December 31, 2009 | 0.00 |
| June 30, 2009 | 0.00 |
| December 31, 2008 | 0.00 |
| June 30, 2008 | 0.00 |
| December 31, 2007 | 0.00 |
| June 30, 2007 | 0.00 |
| December 31, 2006 | 0.00 |
| June 30, 2006 | 0.00 |
| December 31, 2005 | 0.00 |
| June 30, 2005 | 0.1337 |
| December 31, 2004 | 0.1033 |
| June 30, 2004 | 0.00 |
| December 31, 2003 | 0.00 |
| June 30, 2003 | 0.00 |
| December 31, 2002 | 0.00 |
| June 30, 2002 | 0.00 |
| December 31, 2001 | 0.00 |
| June 30, 2001 | 0.00 |
| December 31, 2000 | 0.00 |
| June 30, 2000 | 0.00 |
| December 31, 1999 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-14.63
Minimum
Jun 2023
0.0052
Maximum
Dec 2019
-1.650
Average
--
Median
Jun 2020
Debt to Equity Ratio Benchmarks
| Alterity Therapeutics Ltd | -- |
| Kazia Therapeutics Ltd | -- |
| Immutep Ltd | -- |
| Mesoblast Ltd | -- |
| Immuron Ltd | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 188.79M |
| Total Liabilities (Quarterly) | 264.60M |
| Shareholders Equity (Quarterly) | -75.81M |
| Current Ratio | 2.938 |
| Net Debt Paydown Yield | -17.92% |